The pathogenesis of inflammation is complex process which is regulated by cytokine networks and the inductions of many pro-inflammatory genes. Nuclear factor-kappa B (NF-kB), which has been implicated in the pathogenesis of many diseases including inflammatory disease, plays key regulatory roles in the transcriptions of pro-inflammatory mediators, such as inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2). NF-kB is a dimer composed of p65 and p50 or p52 subunits and is located in the cytoplasm, where it is held by its endogenous inhibitor inhibitory kappa B (IkB). However, in response to pro-inflammatory stimuli, IkB kinase (IKK) signalosome complex induces the phosphorylation of the IkB at two critical residues (Ser32 and Ser36), which results in the ubiquitination and degradation of IkB. Consequently, the free NF-kB translocates to the nucleus and binds to kB binding sites in the promoter regions of target genes. [2] [3] [4] iNOS and COX-2 are known to produce pro-inflammatory mediators, such as nitric oxide and prostaglandins at inflammatory sites. In particular, iNOS stimulates the oxidative deamination of L-arginine to produce nitric oxide (NO), a potent pro-inflammatory mediator. 5) Despite its beneficial role in host defense, sustained NO production can be harmful to the host. COX-2 is another enzyme that plays a key role in the mediation of inflammation by stimulating the biosynthesis of prostaglandins. In contrast to COX-1, COX-2 is barely detectable under normal physiological conditions, but it can be rapidly induced by pro-inflammatory mediators and mitogenic stimuli, such as cytokines, endotoxins, growth factors, oncogenes, and phorbol esters.
Macrophages, which are widely distributed in the body, play a key role in inflammatory processes by providing an immediate defense against foreign agents prior to leukocyte migration. Lipopolysaccharide (LPS, a bacterial endotoxin) triggers the production of inflammatory mediators, such as iNOS, COX-2, tumor necrosis factor-a (TNF-a), and interleukins (ILs) in macrophages. 6, 7) Furthermore, the pharmacological reduction of LPS-inducible inflammatory mediators is regarded as an effective therapeutic strategy for alleviating a variety of disorders, including inflammatory conditions caused by macrophage activation. Furthermore, the RAW 264.7, a murine macrophage cell line, is an excellent model for anti-inflammatory drug screening and for subsequently evaluating the inhibitors of the pathways that lead to the inductions of pro-inflammatory enzymes and cytokines.
Plants are an important source of drug, which chemically leads to the identification of novel anti-inflammatory agents. Dictamnus dasycarpus TURCZ (Rutaceae) is widely distributed in Korea and China, and root bark of this plant has been used in Korean traditional medicine to treat jaundice, rheumatism, headache, colds, and pruritus. 8) penes, and sesquiterpepne glycosides. [9] [10] [11] Fraxinellone, which is formed by the degradation of limonoids, has been reported to ameliorate infertility, 12) to act as a vasorelaxant, 13) to have neuroprotective properties, 14) and to deter insects. 15) The limonoids are highly oxygenated terpenoids and have a range of pharmacological activities in man, for example, anti-bacterial, anti-fungal, anti-malarial, anticancer, and antiviral effects. 16) However, the molecular mechanisms that underlie the anti-inflammatory effects of limonoids have not been investigated. Therefore, as a part of our ongoing research on the anti-inflammatory properties of natural compounds, we investigated the anti-inflammatory effects of fraxinellone, which was isolated from the roots bark of D. dasycarpus, in RAW 264.7 cell lines, which can be stimulated with LPS to mimic the condition of infection and inflammation.
MATERIALS AND METHODS

Plant Material and Isolation of Fraxinellone
The root bark of Dictamnus dasycarpus TURCZ (Rutaceae) was purchased from the Chun-Il Oriental Herbal Store in Wonju, Korea, in May 2005 and the plant origin was identified by S. Y. Yun (Department of Botanical Resources, Sangji University, Korea). A voucher specimen (#NATCHEM-102) was deposited in the Laboratory of Natural Products Analysis, Division of Applied Plant Sciences, Sangji University. Dried root bark of D. dasycarpus (5 kg) was extracted with MeOH three times under reflux. The extracted solution was filtered and dried on a rotatory evaporator under reduced pressure to give the solid MeOH extract (490 g). A part of the MeOH extract (450 g) was suspended in distilled water (1 l) and fractionated three times versus n-hexane (1 l). The n-hexane soluble fractions were dried in vacuo to yield n-hexane fraction (60 g). The n-hexane fraction (50 g) was chromatographed on a silica gel column (500 g, Merck, Art 7734, Germany) using hexane-ethylacetate (10 : 0-1 : 10, gradient) as eluent to give five fractions (Fr. 1-Fr. 5). The Fr. 2 was repeatedly recrystallized from n-hexane-ethylacetate and to yield compound 1 (colorless needle, 1.08 g). Compound 1 was identified as fraxinellone (Fig. 1) Cell Culture and Sample Treatment The RAW 264.7 macrophage cell line was obtained from the Korea Cell Line Bank (Seoul, Korea). Cells were grown at 37°C in DMEM supplemented with 10% FBS, penicillin (100 units/ml), and streptomycin sulfate (100 mg/ml) in a humidified 5% CO 2 atmosphere. Cells were incubated with fraxinellone at the indicated concentrations, and then stimulated with LPS 1 mg/ml for the indicated time.
Nitrite Determination RAW 264.7 cells were plated at 4ϫ10 5 cells/well in 24 well plates and then incubated with or without LPS (1 mg/ml) in the absence or presence of various concentrations (6.25, 12.5, 25 mM) of fraxinellone for 24 h. Nitrite levels in culture media were determined using the Griess reaction and presumed to reflect NO levels. 19) Briefly, 100 ml of cell culture medium was mixed with 100 ml of Griess reagent [equal volumes of 1% (w/v) sulfanilamide in 5% (v/v) phosphoric acid and 0.1% (w/v) naphtylethylenediamine-HCl] and incubated at room temperature for 10 min. The absorbance was then measured at 540 nm using a microplate reader (Perkin-Elmer Cetus, Foster City, CA, U.S.A.). Fresh culture media were used as blanks in all experiments. Nitrite levels in samples were read off a standard sodium nitrite curve. PGE 2 Assays RAW 264.7 cells were pretreated with fraxinellone for 1 h and then stimulated with LPS (1 mg/ml) for 24 h. Levels of prostaglandin E 2 (PGE 2 ) in the culture media were quantified using EIA kits (R&D Systems, Minneapolis, MN, U.S.A.).
Western Blot Analysis Control and fraxinellone-treated RAW 264.7 cells were collected by centrifugation and washed once with phosphate-buffered saline (PBS). Washed cell pellets were resuspended in extraction lysis buffer [50 mM HEPES pH 7.0, 250 mM NaCl, 5 mM EDTA, 0.1% Nonidet P-40, 1 mM PMSF, 0.5 mM DTT, 5 mM NaF and 0.5 mM sodium orthovanadate] containing 5 mg/ml of leupeptin and aprotinin, respectively, and incubated for 20 min at 4°C. Cell debris was removed by microcentrifugation, and supernatants were rapidly frozen. Protein concentrations were determined using Bio-Rad protein assay reagent, according to the manufacturer's instructions. Forty micrograms of cellular proteins from treated or untreated cell extracts were separated on 10% sodium dodesyl sulfate-polyacrylamide gels and electroblotted onto nitrocellulose membranes, which were incubated overnight with blocking solution (5% skim milk) at 4°C, and then with primary antibody for 4 h. Blots were then washed four times with Tween 20/Trisbuffered saline (TTBS), incubated with a 1 : 1000 dilution of horseradish peroxidase-conjugated secondary antibody for 1 h at room temperature, rewashed three times with TTBS, and then developed by enhanced chemiluminescence (Amersham Life Science).
RNA Preparation and Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) Total cellular RNA was isolated using Easy Blue kits (Intron Biotechnology, Seoul, Korea). From each sample, 1 mg of RNA was RT using MuLV RT, 1 mM dNTP, and oligo (dT [12] [13] [14] [15] [16] [17] [18] ) 0.5 mg/ml. PCR was performed on aliquots of the cDNA preparations to detect iNOS, COX-2, and b-actin (the internal standard) gene expressions using a thermal cycler (Perkin-Elmer Cetus, Foster City, CA, U.S.A.). Reactions were carried out in a volume of 25 ml containing; 1 unit of Taq DNA polymerase, 0.2 mM dNTP, 10ϫ reaction buffer, and 100 pmol of 5Ј-and 3Ј-primers. After an initial denaturation for 2 min at 95°C, 30 amplification cycles were performed for iNOS (1 min at 95°C denaturation, 1 min at 60°C annealing, and 1.5 min at 72°C extension), COX-2 (1 min at 94°C, 1 min at 60°C, and 1 min at 72°C), and b-actin (1 min of 94°C denaturation, 1 min of 60°C annealing, and 1 min 72°C extension). PCR primers used in this study are listed below and were purchased from Bioneer: sense strand iNOS, 5Ј-AATG-GCAACATC-AGGTCGGCCATCACT-3Ј; antisense strand iNOS, 5Ј-GCTGTGTGTCACAGAAGTCTCGAA-CTC-3Ј; sense strand COX-2, 5Ј-GGAGAGACTATCAAGATAGT-3Ј; antisense strand COX-2, 5Ј-ATGGTCAGTAGACTTTTACA-3Ј; and sense strand b-actin, 5Ј-TCATGAAGTGTGACG-TTGACATCCGT-3Ј; antisense strand b-actin, 5Ј-CCTA-GAAGCATTTGCGGTGCACGATG-3Ј. After amplification, portions of the PCR reactions were electrophoresed on 2% agarose gel, and visualized under UV after ethidium bromide staining.
Nuclear Extraction and Electrophoretic Mobility Shift Assay (EMSA) RAW 264.7 macrophages cells were plated in 100 mm dishes (1ϫ10 6 cells/ml), and treated with fraxinellone in a time-and dose-dependent manner, stimulated with LPS for 1 h, washed once with PBS, scraped into 1 ml of cold PBS, and pelleted by centrifugation. Nuclear extracts were prepared as described previously. 19) Cell pellets were resuspended in hypotonic buffer (10 mM HEPES, pH 7.9, 1.5 mM MgCl 2 , 10 mM KCl, 0.2 mM PMSF, 0.5 mM DTT, and 10 mg/ml aprotinin) and incubated on ice for 15 min. Cells were then lysed by adding 0.1% Nonidet P-40 and vortexed vigorously for 10 s. Nuclei were pelleted by centrifugation at 12000ϫg for 1 min at 4°C and resuspended in high salt buffer (20 mM HEPES, pH 7.9, 25% glycerol, 400 mM KCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM DTT, 1 mM NaF, and 1 mM sodium orthovanadate). Nuclear extracts (10 mg) were mixed with double-stranded NF-kB oligonucleotide. 5Ј-AGTTGAGGGGACT-TTCCCAGGC-3Ј end-labeled with [g-32 P] dATP (underlying indicates a kB consensus sequence or a binding site for NF-kB/cRel homodimeric or heterodimeric complex). Binding reactions were performed at 37°C for 30 min in 30 ml of reaction buffer containing 10 mM Tris-HCl, pH 7.5, 100 mM NaCl, 1 mM EDTA, 4% glycerol, 1 mg of poly (dI-dC), and 1 mM DTT. The specificity of binding was examined by competition with the 80-fold unlabeled oligonucleotide. DNA-protein complexes were separated from the unbound DNA probe on native 5% polyacrylamide gels at 100 V in 0.5ϫTris-Boric acid EDTA (TBE) buffer. Gels were vacuum-dried for 1 h at 80°C and exposed to Xray film at 70°C for 24 h.
Transient Transfection and Luciferase Assay RAW 264.7 cells were transfected using Superfect reagent (Qiagen GmbH, Germany) and NF-kB-Luc reporter plasmid (BD Biosciences, San Jose, CA, U.S.A.), according to the manufacturer's instructions. Cells were incubated for 2 h before adding 5 ml of DMEM containing 10% FBS. At 48 h after the start of transfection, cells were pretreated with fraxinellone for 1 h and then stimulated with LPS (1 mg/ml). After 3 h of stimulation, cells were lysed, and luciferase activity was determined using the Promega luciferase assay system (Promega, Madison, CA, U.S.A.) and a luminometer (PerkinElmer Cetus, Foster City, CA, U.S.A.).
Immunoprecipitation and IKK Assay Whole cell extracts were lysed with lysis buffer (10% glycerol, 1% Triton X-100, 1 mM EGTA, 5 mM EDTA, 1 mM sodium pyrophosphate, 20 mM Tris-HCl, pH 7.9, 10 mM b-glycerophosphate, 137 mM NaCl, 1 mM PMSF, 10 mM NaF, 1 mM sodium orthovanadate, and protease inhibitor cocktail) for 15 min at 4°C. Equal amounts of total cellular protein were immunoprecipitated with anti-IKKb monoclonal antibody in TNT buffer (20 mM NaCl, 20 mM Tris-HCl, pH 7.5, 1% Triton X-100, 300 mM sodium orthovanadate, 2 mM PMSF, and protease inhibitor cocktail). The IKKb-antibody complex was precipitated with protein A/G-Sepharose beads for 4 h at 4°C. The kinase assay was carried out in kinase buffer containing 5 mCi [g- 
RESULTS
Effects of Fraxinellone on LPS-Induced NO and PGE 2 Production
To investigate the effects of fraxinellone on LPS-induced NO and PGE 2 production in RAW 264.7 cells, culture media were harvested, and nitrite and PGE 2 levels were determined. As shown in Fig. 2A , LPS (1 mg/ml) increased NO production by approximately 100 fold, but when fraxinellone was pretreated at 6.25, 12.5, and 25 mM for 1 h before LPS was treated, NO production was found to have decreased by 69, 72 and 83%, respectively. L-N 6 -(1-iminoethyl) lysine (L-NIL) (10 mM) was used as a positive NO production inhibitor. To examine whether fraxinellone inhibits PGE 2 production, cells were preincubated with fraxinellone (6.25, 12.5, 25 mM) for 1 h and then activated with 1 mg/ml LPS for 24 h. As shown in Fig. 2B , fraxinellone was found to significantly attenuate the production of PGE 2 in a dose-dependent manner. NS-398 was used as a COX-2 selective inhibitor and showed significant inhibitory effects upon PGE 2 production. In addition, the cytotoxic effects of frax-inellone at the concentrations mentioned above were evaluated in RAW 264.7 cells in the presence or absence of 1 mg/ml of LPS using MTT assays, but no effect on cell viability was observed (data not shown), indicating that the inhibitory effects observed were not attributable to cytotoxic effects.
Effects of Fraxinellone on the LPS-Induced mRNA and Protein Expressions of iNOS and COX-2 RT-PCR and
Western blotting were used to determine whether the inhibitory effects of fraxinellone on the productions of NO and PGE 2 were related to changes in the expressions of iNOS and COX-2. The mRNA levels of iNOS and COX-2 were significantly up-regulated in response to 1 mg/ml LPS, and fraxinellone at 6.25, 12.5, and 25 mM markedly and dose-dependently inhibited these mRNA expressions (Fig. 3A) . Furthermore, Western blotting also showed that fraxinellone dose-dependently inhibited iNOS and COX-2 at the protein level (Fig.  3B ). However, fraxinellone had no effect on the expression of b-actin, the housekeeping gene.
Effects of Fraxinellone on LPS-Induced NF-k kB-DNA Binding and NF-k kB Transcriptional Activity Because NF-kB activation is critically required for the expressions of iNOS and COX-2 by LPS, EMSAs and luciferase assays were performed to determine whether fraxinellone suppresses NF-kB activation. Accordingly, NF-kB to DNA binding assay was carried out using nuclear extracts obtained from RAW 264.7 cells stimulated with LPS in the presence or in the absence of fraxinellone. Treatment with LPS (1 mg/ml) was found to increase NF-kB-DNA binding, and fraxinellone pretreatment decreased LPS-induced NF-kB-DNA binding in a time-and dose-dependent manner (Figs.  4A, B) . We also examined the effects of fraxinellone on NFkB-dependent reporter gene expression induced by LPS. Accordingly, RAW 264.7 cells were transiently transfected with pNF-kB-luc vector and then stimulated with 1 mg/ml LPS with/without fraxinellone. Treatment with fraxinellone (12.5 mM) was found to significantly reduce LPS-induced increases in NF-kB-dependent luciferase activity (Fig. 4C) .
Inhibitory Effects of Fraxinellone on the LPS-Induced Phosphorylation of Ik kB-a a and on the Nuclear Translocation of p65
In unstimulated cells, NF-kB is sequestered in the cytosol by its inhibitor IkB, which upon LPS stimulation is phosphorylated by its inhibitor IkB kinases, ubiquitinated, and rapidly degraded via 26S proteosome, thus releasing NFkB. We examined the effect of fraxinellone on the LPS-induced degradation and phosphorylation of IkB-a using Western blot assay. Fraxinellone was found to significantly inhibit LPS-induced IkB-a phosphorylation and degradation in a dose-dependent manner (Fig. 5A) . Furthermore, we confirmed that the LPS-induced phosphorylation and degrada- 
. Effects of Fraxinellone on LPS-Induced NO (A) and PGE 2 (B) Production in RAW 264.7 Cells
(A) Cells were treated with different concentrations (6.25, 12.5, 25 mM) of fraxinellone for 1 h and then with LPS (1 mg/ml), and incubated for 24 h. Control (Con) values were obtained in the absence of LPS and fraxinellone. Nitrite levels in culture media were determined using Griess assays and were presumed to reflect NO levels. L-NIL was used as a positive control at a concentration of 10 mM. (B) Samples were treated as described in the legend of panel A. NS-398 (10 mM) was used as a positive control. Levels of PGE 2 in culture media were quantified using EIA kits. Data are presented as meansϮS.D. of three independent experiments. # pϽ0.05 vs. the control group; * pϽ0.05, * * pϽ0.01, * * * pϽ0.001 vs. the LPS-treated group. Significances between treated groups were determined using ANOVA and Dunnett's post-hoc test (A, B).
Fig. 3. Effects of Fraxinellone on LPS-Induced iNOS and COX-2 mRNA (A) and Their Protein (B) Expressions in RAW 264.7 Cells
(A) Total RNA was prepared for RT-PCR from RAW 264.7 macrophages treated with different concentrations (6.25, 12.5, 25 mM) of fraxinellone for 1 h followed by LPS (1 mg/ml) for 4 h. iNOS-specific sequences (807 bp) and COX-2-specific sequences (721 bp) were detected by agarose gel electrophoresis, as described in Materials and Methods. PCR of b-actin was performed to verify that the initial cDNA contents of samples were similar. Experiments were repeated three times, and similar results were obtained. (B) Cells were treated with different concentrations (6.25, 12.5, 25 mM) of fraxinellone for 1 h and then with LPS (1 mg/ml), and incubated for 24 h. Control (Con) values were obtained in the absence of LPS and fraxinellone. Total cellular proteins (40 mg) were resolved by SDS-PAGE, transferred to nitrocellulose membranes, and detected using specific antibodies for COX-2 and iNOS, as described in Materials and Methods. A representative immunoblot of the three separate experiments is shown. The density ratios of fraxinellone plus LPS-treated cells versus LPS onlytreated cells or untreated control cells were measured by a densitometer.
tion of IkB-a were significantly blocked at 5-10 min by pre-treating cells with fraxinellone (12.5mM). In addition, we investigated whether fraxinellone prevented the translocation of the p65 subunit of NF-kB from the cytosol to the nucleus after its release from IkBs. In the case of the pre-treatment with fraxinellone, a decrease in the level of p65 in the nuclear fraction was detected by Western blot analysis until 60 min (Fig. 5B) . b-Actin and PARP were used as internal controls.
Effects of Fraxinellone on the LPS-Induced Activations of IKK and MAPK Since IKK is an upstream kinase of IkB in the NF-kB signal pathway, and in particular, phosphorylates IkB-a and -b, 20) we examined the effects of fraxinellone on LPS-induced IKK activity using GST-IkB fusion protein as a substrate for IKK. Experiments showed that fraxinellone (12.5 mM) strongly inhibited LPS-induced IKK activity (Fig. 6A) . To investigate whether the inhibition of NFkB activation by fraxinellone is mediated through the mitogen-activated protein kinases (MAPK) pathway, we examined the effect of fraxinellone on the LPS-stimulated phosphorylations of ERK1/2, JNK1/2, and p38 MAP kinases in RAW 264.7 cells. Maximal MAPK (ERK1/2, p38, and JNK1/2) phosphoprotein expression levels are known to occur 5-30 min after LPS treatment in human and murine macrophages. Therefore, we are carried out Western blotting for MAPKs after treating with LPS (1 mg/ml) for 5 to 30 min. Cells were transiently cotransfected with pNF-kB-luc reporter and either left untreated (Con) or pretreated with fraxinellone (12.5 mM) for 1 h. LPS (1 mg/ml) was then added, and cells were further incubated for 3 h. Cells were then harvested and luciferase activities were determined using a Promega luciferase assay system and a luminometer. The values shown are meansϮS.D. of three independent experiments. # pϽ0.05 vs. the control group, and * * pϽ0.01 vs. the LPS-treated group. Significances between treated groups were determined using ANOVA and Dunnett's post-hoc test. Total cell lysates were then probed with phosphospecific antibodies for p38, ERK1/2, and JNK1/2. The phosphorylations of p38, ERK1/2, and JNK1/2 were found to be increased in cells treated with LPS alone, but fraxinellone pretreatment suppressed phosphorylated ERK1/2 levels induced by LPS in RAW 264.7 cells in a time-dependent manner, but fraxinellone did not affect phosphorylated p38 and JNK1/2 levels. On the other hand, non-phosphorylated ERK1/2, JNK1/2, and p38 kinase expressions were unaffected by LPS or by LPS plus fraxinellone.
DISCUSSION
The limonoids are highly oxygenated naturally occurring terpenoids, and have been shown to have anti-cancer, antimalarial, anti-microbial, and anti-HIV effects in man. [21] [22] [23] However, the biological activities of the limonoid fraxinellone have not been previously studied. Yoon et al. demonstrated that fraxinellone and five limonoids isolated from Dictamnus dasycarpus exhibited significant inhibitory effects on glutamate-induced neurotoxicity in primary cultures of rat cortical cells, 14) and fraxinellone inhibited Ca 2ϩ -induced vasoconstriction of rat aorta but not noradrenalinestimulated tonic contraction in an ex vivo study, which suggests that fraxinellone selectively blocks voltage-dependent Ca 2ϩ channels. 15) Liu et al. found that fraxinellone and dictamnine, isolated from the methanol extract of Dictamnus dasycarpus by bioassay-guided fractionation, possessed significant feeding deterrence against two stored-product insects (Tribolium castaneum and Sitophilus zeamais). 15) We undertook the present study to investigate the anti-inflammatory effects of fraxinellone in LPS-treated RAW 264.7 macrophages, and to the best of our knowledge, the present study is the first to report that fraxinellone has an anti-inflammatory effect and to describe the molecular basis for its action.
Macrophages are widely distributed throughout the body, and participate in both adaptive and innate immunity, and in particular, play crucial roles during inflammatory response. Toll-like receptors (TLRs) on the surfaces of macrophages facilitate pathogen recognition, and LPS stimulates toll-like receptor 4 (TLR4), which triggers the recruitment of cytoplasmic adaptor protein MyD88, and the subsequent activations of two distinct downstream signaling pathways; the NFkB pathway and the MAP kinase pathway, 24) which induce the expressions of various inflammatory mediators including NO, PGs, and other pro-inflammatory cytokines. 25) NO is an important regulatory molecule in a range of physiological and pathological processes. Physiologically, appropriate levels of NO are required for smooth muscle relaxation, platelet inhibition, neurotransmission, immune regulation, and vasodilation. In contrast, chronic expose to NO has been implicated in a number of pathogenic conditions including inflammatory diseases, such as arthritis, bronchitis, gastritis, and multiple sclerosis. NO is generated from Larginine by the NO synthases in vertebrates, and whereas endothelial NOS (eNOS) and neuronal NOS (nNOS) are constitutively expressed, inducible NOS (iNOS) is mainly produced by stimulated macrophages. In view of the fact that excess NO production, especially in macrophages, can lead to cytotoxicity, inflammation, carcinogenicity, and autoimmune disorders it appears reasonable that the inhibitions of NO and iNOS could prevent inflammatory diseases. In the present study, fraxinellone was found to significantly and dose-dependently suppress LPS-stimulated NO production in RAW 264.7 cells, which appears to be due to its ability to inhibit the expressions of iNOS at the mRNA and protein levels.
PGE 2 is also a major inflammatory mediator and enhances vascular permeability, which can result in fever, edema, and pain at sites of inflammation. Members of the COX family are responsible for the formation of prostaglandins as well as prostacyclin and thromboxanes. COX exits as two isoforms; constitutive COX-1 and inducible COX-2, and the inhibition of COX-2 can provide relief from symptoms of inflammation and pain. COX-2 is barely detectable under normal physiological conditions, but is rapidly and transiently induced by pro-inflammatory mediators, whereupon it stimulates the biosynthesis of PG, and thus, inflammatory responses. Accordingly, intense research has been undertaken to search for selective COX-2 inhibitors. The present study demonstrates that fraxinellone has mild but significant inhibitory effects on the stimulation of PGE 2 by LPS, and our findings suggest that the observed reductions in PGE 2 may be due to the transcriptional suppression of COX-2.
NF-kB regulates the expressions of genes encoding proinflammatory inducible enzymes, such as COX-2, iNOS, and other inflammatory-related proteins. 26) Since the expressions (A) Cells were pretreated with fraxinellone (12.5 mM) for 1 h and then stimulated with LPS (1 mg/ml) for 1 h. IKK-immuno complex was prepared from total cell lysates, and its kinase activity was assayed using GST-IkB-a as substrate, as described in Materials and Methods. (B) Cells were pretreated with fraxinellone (12.5 mM) for 5, 10, 15, 30, and 60 min and then treated with LPS (1 mg/ml). Lysates were analyzed by Western blot analysis using specific pERK1/2, pJNK1/2, p-p38, ERK1/2, JNK1/2, and p38 antibodies. The data shown are representative of three independent experiments. The density ratios of fraxinellone plus LPS-treated cells versus LPS only-treated cells or untreated control cells were measured by a densitometer.
of these pro-inflammatory mediators are known to be modulated by NF-kB, our findings suggest that the transcriptional inhibitions of these pro-inflammatory mediators by fraxinellone are due to its blocking of the NF-kB signal pathway. We also found that the degradation and phosphorylation of IkBa and the translocation of activated NF-kB to the nucleus are significantly inhibited by fraxinellone. These data indicate that fraxinellone may inhibit NF-kB activation by suppressing the degradation and phosphorylation of IkB-a, and the translocation of the p65 subunit of NF-kB from the cytosol to the nucleus in LPS-induced RAW 264.7 cells. IKK, heterotetrameric complexes, are responsible for the phosphorylations of two serine residues (Ser32 and Ser36) located in the IkB regulatory domain, which results in the degradation of phosphorylated IkB. 27) In the present study, we demonstrate that the LPS-stimulated kinase activity of IKK was significantly abolished by fraxinellone, which suggests that IKK is involved in the negative regulation of the NF-kB pathway by fraxinellone.
In view of the mounting evidence of cross-talk between MAPK and NF-kB, 28) we examined the effect of fraxinellone on the MAPK pathway. The MAPK family is composed of serine and threonine kinases that are activated in response to diverse extracelluar stimuli, and which mediate signal transduction from the cell surface to the nucleus. 29, 30) The MAPKs are divided into three major subgroups: ERK1/2, JNK1/2, and p38, of which ERK1/2 (p44/42 MAPK) have been most extensively studied. The intracellular signals arising from MAPK cascades invariably lead to the activations of molecules that regulate cell growth, division, and/or differentiation, and they are also known to be important for the activation of NF-kB. 31) It has been previously reported that SB203580 (a p38 inhibitor) and PD0980589 (an ERK inhibitor) significantly suppress the transcriptional activation of the p65 kB subunit in the L929 mouse fibrosarcoma cell line. 31) In the present study, we observed that fraxinellone significantly inhibited ERK1/2 phosphorylation and IkB activity, which suggests that fraxinellone-inhibited NF-kB signaling is likely to be mediated by the IKK and ERK1/2 signaling pathway in RAW 264.7 cells. Moreover, several transcription factor binding sites are located in the promoter of the iNOS and COX-2 genes, and NF-kB and activator protein-1 (AP-1) are principally involved in LPS-mediated NO and PGE 2 production. 20) Further molecular investigations on the transcription factors including AP-1 via MAPK cascades are needed.
Taken together, our results demonstrate that fraxinellone significantly suppresses the LPS-induced expressions of iNOS and COX-2, which reduces NO and PGE 2 production by inhibiting the degradation and phosphorylation of IkB-a, and thus, blocks the activation of NF-kB in RAW 264.7 cells. We suggest that the anti-inflammatory effects of fraxinellone may also be accomplished by reducing NF-kB activation via the IKK and MAP kinases signal pathways. Accordingly, our results suggest that fraxinellone should be considered a potential treatment for inflammatory diseases.
